Monthly Archives: December 2019

Rekor’s ‘Rekor Edge’ Fixed Camera Vehicle Recognition System Selected by Sands Point Police Department to Increase Public Safety

Long Island police department to utilize Rekor's "plug-and-play" vehicle recognition system and powerful Watchman software for license plate reads with up to 99% accuracy; Sands Point also joins Rekor Public Safety Network

COLUMBIA, MD / ACCESSWIRE / December 12, 2019 / Rekor Systems, Inc. (NASDAQ:REKR) ("Rekor"), a Nasdaq company focused on bringing smarter, faster, cost-competitive solutions to the worlds of public safety and customer experience, announced today it has been selected by the Sands Point Police Department ("SPPD") of Long Island, New York to provide robust vehicle recognition solutions.

SPPD will utilize the Rekor Edge "plug-and-play" fixed camera vehicle recognition system to increase public safety and help identify and recover stolen vehicles. Rekor's system will replace a legacy camera system that was failing to meet SPPD's needs.

"We are excited to integrate the Rekor Edge and Watchman vehicle recognition technology into our daily public safety efforts. With higher accuracy than our previous hardware, as well as the ability to affordably scale, Rekor's solutions fit the needs of our department both now and for the future," said Thomas Ruehle, Chief of Police, SPPD. "We also look forward to being a part of the Rekor Public Safety Network and enhancing public safety both in our communities in New York and beyond."

As a part of its subscription, and at no additional cost, the SPPD will be joining the Rekor Public Safety Network ("RPSN"). Any state or local law enforcement agency participating in the RPSN will be able to access real time data from any part of the network at no cost. The Company is initially launching the network by aggregating vehicle data from customers in over 30 states. With thousands of automatic license plate reading cameras currently in service that capture approximately 30 million plate reads per week, the network is expected to be live by the first quarter of 2020.

"We are proud to partner with yet another New York law enforcement agency, and to provide SPPD with the innovative technologies they need to help keep their community safe," said Robert A. Berman, President and CEO, Rekor. "Our scalable vehicle recognition system enables law enforcement agencies of all sizes the ability to utilize powerful technologies that can enhance public safety, no matter their budget. This access also allows us to continue to build our Rekor Public Safety Network, which we believe will be a game-changer for cooperative law enforcement activity nationwide."

Rather than buying expensive new cameras that take weeks or months to ship and install, Rekor's software can be deployed to support existing traffic or surveillance cameras immediately. It eliminates the need for two separate cameras – one for vehicle recognition functionality, one for general surveillance recording – as Rekor's solution can be used to collect license plate data and information such as the make, type, and color of a vehicle using the same camera that provides surveillance monitoring. This can represent substantial savings per camera, as well as greater flexibility to expand or decrease usage as needed without large capital expenditures on hardware.

To learn more about Rekor's vehicle recognition software, please visit our website.

About Rekor Systems, Inc.

Rekor Systems, Inc. is a publicly traded company listed on Nasdaq (REKR) with headquarters in Columbia, Maryland. Rekor is focused on bringing smarter, faster, cost-competitive solutions to the worlds of public safety and customer experience. With a strong presence in over seventy countries across the world, we use the power of artificial intelligence to provide actionable, vital information for our clients. Whether it's using machine learning software to give those who protect us better tools to keep us safe, or through solutions tailored to improving the everyday lives of everyday people, Rekor has the tech, and the expertise, for the job. At Rekor, we strive to make the impossible … possible. To learn more please visit our website: https://rekorsystems.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. Other than statements of historical facts, all statements contained in this press release are forward-looking statements, including particularly statements regarding our future results of operations and financial position, business strategy, prospective products and services, timing and likelihood of success, plans and objectives of management for future operations, and future results of current and anticipated products and services. These statements involve uncertainties, such as known and unknown risks, and are dependent on other important factors that may cause our actual results, performance or achievements to be materially different from the future results, performance or achievements we express or imply. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these terms or other similar expressions. All forward-looking statements contained in this press release speak only as of the date on which they were made, are based on management's assumptions and estimates as of such date and are subject to a number of risks, uncertainties and assumptions, including those described under the sections in our Annual and Quarterly Reports filed with the Securities and Exchange Commission. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond our control, you should not rely on these forward-looking statements as predictions of future events. We undertake no obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events, or otherwise.

Media Contact:

Matthew Bretzius
FischTank Marketing and PR
matt@fischtankpr.com

Investor Contact:

Charles Degliomini
Rekor Systems, Inc.
ir@rekorsystems.com

SOURCE: Rekor Systems, Inc.

ReleaseID: 569935

PUC and Smuzcity Roll Out JDX Presto Concept Store on 12.12

Kuala Lumpur, Malaysia – December 12, 2019 /PRWIRE.asia/

JDX Presto Concept Store, the largest cashless concept store in ASEAN, celebrates its official grand opening at Quill City Mall KL today. The partnership between PUC Berhad (“PUC”) and Smuzcity Berhad (“Smuzcity”) in launching their first Online-to-Offline (“O2O”) store signifies the joint effort of the two parties to create a cashless retail scenario in Malaysia.

Grand opening of JDX Presto Concept Store on 12.12 at Quill City Mall KL officiated by:
– Senior Vice President of Quill City Mall KL, Justin Liew (L-1)
– Group CEO of Quill Group of Companies, Koong Wai Seng (L-3)
– Group MD & CEO of PUC Berhad, Cheong Chia Chou (L-5)
– Senior Manager of International Business Division Supply Chain & Logistics Dept. of JD Logistics, Gary Sun (L-6)
– Y.M. Tengku Dato’ Hishammuddin Zaizi bin Y.A.M. Tengku Azman Shah Alhaj (L-7)
– Acting Chairman of Malaysia Digital Economy Corporation (MDEC), YBhg. Dato’ Mathialakan Chelliah (R-6)
– Founder of Smuzcity Berhad, Kent Lee (R-5)
– Group Executive Director of Quill Group of Companies, Dato’ Ar. Michael Ong (R-3)

Spanning a total 50,000 square feet in the strategically located Quill City Mall KL on Level 3 (Lot 63, 63B and 72), JDX Presto Concept Store hosts products from a host of brands covering categories such as Electrical Appliances, Gadgets, Health & Beauty, Home & Living, Fashion and Food & Beverage, with a total of up to 3,000 Stock Keeping Units (SKUs) from J.Zao, as well as other top selling products from China and the ASEAN region.

It is easy to begin shopping around the store. Shoppers just need to scan the QR code of their selected product with the Presto app and enjoy a hassle-free payment experience by checking out with the eWallet named PrestoPay in the app. Shoppers can opt for on-the-spot self-pickup or for convenient delivery to doorstep, supported by JD Logistics, the logistics affiliate of JD.com, China’s largest retailer.

Shoppers can take a break from their shopping sprees and enjoy some refreshments from the AI- and RFID-powered JDX Presto Unmanned Fridges, developed by JD Logistics’ logistics innovation lab, JDX, that are available at the in-store cafe. By scanning the displayed QR code with Presto app, shoppers are able to unlock the fridge and pick their favourite products off the shelves. Payment will be deducted from PrestoPay accordingly after the door is closed.

In line with the government’s roadmap to transform Malaysia into a cashless society, PUC has fully embraced digital finance, from the inclusion of PrestoPay to the introduction of micro-financing facility, PrestoPay Credit Financing to its ecosystem. At JDX Presto Concept Store, every transaction is cashless and seamless.

Group Managing Director and Chief Executive Officer of PUC Berhad, CHEONG Chia Chou said, “We proudly launched Presto two years ago, and along the way, our teams have worked relentlessly to gradually enrich Presto with various digital offerings. Today truly marks a great milestone on our journey, with the grand opening of our first ever O2O store. We are excited to extend to Malaysians the opportunity to first explore JDX innovations via PrestoMall and then complete the shopping journey by visiting JDX Presto Concept Store or vice versa, as we believe that the integrated experience is important for consumers to touch and feel the actual products, providing a sense of certainty to consumers with lesser or no experience in online purchase.”

Cheong added, “The symbol for Presto is a rabbit. It was chosen as the central character due to its fun-loving personality, its alertness, its ability to navigate challenges effortlessly, and the way it sprints and leaps at lightning speed, reflecting the brand’s propensity for growth. With the launch of our first O2O store, shoppers are welcome to meet and take a photo with Presto, doubling the joy of shopping with fun and interactive elements. Presto-themed merchandise is also available in the store for Presto lovers.”

Founder of Smuzcity, Kent Lee Kian Yan shared, “We are proud to leverage JDX technology to bring increased cashless convenience to shoppers in Malaysia through homegrown super app Presto.”

“Ever picture yourself shopping in shopping mall without your wallet? With a smartphone in hand, your shopping journey is now good to go. Together with PUC, we are committed to add a touch of innovation to the retail scene, redefining and shaping a unique O2O shopping experience for Malaysians,” Lee added.

Official venue partner, Group Executive Director of Quill Group of Companies, Dato’ Ar. Michael Ong said, “Our retail mall offers utmost support to the adoption of digital payment that is a win-win for both shoppers and sellers. Back in May, Presto held their first Cashless Raya Bazaar at Quill City Mall KL to encourage and educate consumers to go cashless while shopping for their Raya needs, which saw a success. We are more than delighted to be part of their adventure in the retail scene.”

Senior Vice President of Quill City Mall KL, Justin Liew added, “As Quill City Mall KL is repositioning itself towards the ‘phygital’ era, JDX Presto Concept Store is very much aligned with the direction we are moving forward. That focuses on consumer-centric technology infrastructure that facilitates the interactions between the consumers and brands. Thus, we are very excited to be able to collaborate with both parties closely in a set of exciting activities; such as, expanding home-grown brands to the international platform.”

In conjunction with the grand opening of JDX Presto Concept Store, the first 300 shoppers will be eligible to purchase selected SKUs at only RM12.12, limited to one item per shopper. Queuing starts at 8am and the doors are open to public at 11am on 12 December 2019. Continuing the celebration, until 15 December 2019, shoppers can spot and scan QR codes placed in the store and the mall to earn free PrestoPay Credits, which can then be spent in store and on any services on Presto.

Adding to the shopping pleasure, 5 shoppers who spend a minimum of RM50 in the store with PrestoPay from 12 December 2019 to 31 December 2019 will have a chance to win a pair of Hong Kong Disneyland Theme Park admission tickets.

Head to Quill City Mall KL and indulge in the joy of shopping now!

Presto app is available for download at Apple Store and Google Play. For more information about Presto, kindly visit https://www.prestouniverse.com/presto.

###

About PUC Berhad
PUC Berhad (“PUC”) was incorporated in Malaysia on 3 November 1997 by China Founder Group. It was listed on the ACE Market of Bursa Malaysia Securities Berhad on 8 April, 2002. Throughout the years, PUC and its subsidiaries have built a solid foundation in integrated media services and payment solutions. In mid-2007, the Group embarked on a digital business journey. Today, the Group’s digital services include financial technology related services, new media, eCommerce, mobile payment, digital imaging, and artificial intelligence. These continuous efforts are in line with the Group’s vision to be a key homegrown digital ecosystem creator. For more information, please visit www.puc.com.

About Smuzcity Berhad
SMUZCITY® Berhad is a public limited company founded on 2016, based in Kuala Lumpur, focuses on rapid urban transformation, defining and nurturing next generation’s need, shaping a smarter habitat for greater freedom. Smuzcity is principally involved in providing O2O solutions based on ‘unmanned’ and ‘cashless’ concepts, allowing users to experience a futuristic lifestyle through technology applications such as Artificial Intelligence (AI) BOT, facial recognition, e-wallets, virtual reality and Internet of Things (IoT). For more information, please visit www.smuzcity.com

About Quill City Mall Kuala Lumpur
Moving forward towards the year 2020 Quill City Mall KL will be repositioning itself as a “phygital” mall that creates a physical space, with consumer-centric tech infrastructure that facilitates the interactions between consumers and brands throughout the shopping experience. Housing various new tenants on board to build their very first “phygital” concept stores in Malaysia naming JDX Presto, E-Sport Arena and UniKL. Located in the heart of Kuala Lumpur, along Jalan Sultan Ismail and spans across with a net lettable area of approx. 780,000 sq.ft. A myriad of retail experiences ranging from fashion and lifestyle, dining, entertainment, accessories, home furnishing, cosmetics, healthcare, food & beverage and a whole lot more under one roof. Signature anchor tenants H&M, Kurasi, Red Lobster, GSC, Celebrity Fitness, AEON MaxValue Prime, Ashley Furniture Homestore, Watson, Miniso, Aragan Yokocho and The Whitehouse.

Media Contact
Grace Chang
PUC Berhad
T: +603-2719 1019
E: grace.chang@puc.com

Lye Yng Shin
PUC Berhad
T: +603-2719 1025
E: yngshin.lye@puc.com

Source: PRWIRE.asia

Release ID: 88939036

Stillcanna Operational Update

Company launches B2B portal at www.stillcannacbd.com

VANCOUVER, BC / ACCESSWIRE / December 12, 2019 / Stillcanna Inc. (OTC PINK:SCNNF)(CSE:STIL)(FRANKFURT:484) ("STIL" or the "Company") is pleased to update shareholders on sales, agriculture and its NEXUS extraction facility in Poland.

Stillcanna is pleased to present its B2B web portal to support its bulk sales initiatives. The Company obtained a comprehensive Certificate of Analysis ("COA") of its CBD Isolate. The COA indicates that the product is pure CBD, has non-detectable levels of THC, and is free of any heavy metals and pesticides ("CBD Isolate"). The COA is available on the Company's B2B portal. The portal also makes available a certificate of Good Farming Practices, EU registered hemp varietals used, a Material Safety Data Sheet and verification of EU GMP compliant construction and anticipated filing for certification. Stillcanna anticipates adding additional certifications to the portal as they become available including Halal, Kosher, Non-GMO, Gluten-free, Organic and others. http://www.stillcannacbd.com.

Since beginning production over the past few weeks, the Company is pleased to announce it has begun shipping CBD Isolate to Bioscience Enterprises Inc. as outlined in the supply agreement dated May 28, 2019. Bioscience has operations in California, the United Kingdom and Ireland. The CBD Isolate shipment was successfully delivered from the Company's Polish based NEXUS extraction facility to Biosciences' United Kingdom office. The Company anticipates ongoing monthly shipments to Biosciences offices globally.

The Company is pleased to announce that it has received and has begun fulfilling an order from HempLabs Poland. Hemplabs specializes in producing and selling various CBD-based products throughout Europe under the brand Cannabium, from its e-commerce site at https://cannabium.pl. Stillcanna anticipates fulfilling the HempLabs order by the end of the month.

The Company is pleased to announce it has begun shipping hemp biomass to Sequoya Cannabis in Poland as outlined in the supply agreement dated August 23, 2019. Sequoya has been successfully testing their CO2 extraction equipment, Stillcanna anticipates shipping hemp to Sequoya on an ongoing monthly basis.

Since producing its first pure CBD Isolate at its NEXUS facility last month, the Company has received over C$1,140,000 in confirmed purchase orders. The Company's production staff in Poland has grown to 20 employees, working 12-hour shifts on a two-day rotation during a seven day work week. The company has every intention of delivering all orders in a timely manner in the weeks ahead.

While transitioning into sales, the Company has established a network of sales agents globally who work in the Cannabis space, referred to as the broker network. The Company is finalizing the required tool set for the network, including commissions, pricing, product documentation and sales protocols. The sales channel is made up of a combination of individuals and corporations that have established customers in the space. The sales cycle generally involves a potential customer first requesting the third party COA, followed by a sample of the Company's product for their own testing, followed by pricing, terms and purchase order. Depending on the customer's size and product requirements, the sales cycles can range from 30 days to 90 days on average, and in the case of large corporations 6 months or more. To help streamline the sales process, the Company has added Matt Human as Sales Operations Manager. With experience in optimizing processes and systems in growing companies, Matt will assist Marc Crimeni in overseeing the B2B sales process as the Company grows its network of customers. As of today, the Company has sent out approximately 50 samples of its CBD Isolate to over 20 countries. In the past 30 days, the Company has attended 5 cannabis tradeshows across Europe including Prague, Malta, the United Kingdom and Poland, identifying many new potential customers. From these new contacts, the Company anticipates shipping additional product samples over the next 10 days, further increasing its opportunity pipeline. For more information please email sales@stillcanna.com.

The design of the NEXUS extraction facility requires an input of consistent hemp biomass, both in physical structure and in CBD concentration in order to streamline and monitor production efficiencies. The facility has the capacity to process 1080 kilos of blended hemp flower at a consistent 6% CBD biomass input into 40 Kilos of CBD Isolate every 12 hours. An average of 75% to 80% percent of the Cannabinoids are captured through the extraction process. The Company intends to blend its own biomass together with third party biomass to create a consistent input material of 6% CBD. If the Company can blend to a higher than 6% consistent input, it will increase extraction productivity. In Q1 of 2020 the Company plans to operate its NEXUS facility 7 days a week, 24 hours a day with the intention of increasing its extraction capabilities.

At completion of its 2019 agricultural initiative, Stillcanna will have 855 bales of hemp flower, nearly 100,000 pounds of seed, and a million pounds of leaf and fiber biomass for industrial uses and CBD extraction. Hemp is one of the most versatile products in the world allowing all parts of the plant to be used across a wide variety of industries; from manufacturing CBD to seed used for agriculture, hemp seed oil and as a protein supplement. Hemp fiber can be sold for clothes, rope, fire logs and more as the Company intends to monetize all its harvested products.

Stillcanna's ORIGIN extraction facility in Romania, a joint venture with its partner Dragonfly Bioscience of the United Kingdom, has received positive feedback regarding its outstanding operational permits from various authorities including local and state fire marshals, the Environmental Agency, the Ministry of Health and the Anti-Drug Agency. All final requests for permits have been filed and the Company remains optimistic that it will receive all permits by January 15, 2020. In addition, the ORIGIN facility recently received and installed a second rotochrome, which has the ability to increase production capacity of THC-free CBD oil once fully operational.

"This is a very exciting time for Stillcanna and our shareholders who have been anticipating proof of concept and sales," says Jason Dussault CEO, Stillcanna "As a Company in this nascent industry, we have learned a great deal about the seed-to-CBD process and have fulfilled and met many of our corporate mandates. I feel we have made great strides in a relatively short time, and the entire Stillcanna team remains dedicated to delivering additional value to our shareholders."

About Stillcanna Inc.

Stillcanna Inc. (CSE: STIL) www.stillcanna.com is a Canadian early-stage life sciences company focused on the large scale manufacturing of CBD in Europe. The Company believes its proprietary intellectual property allows it to extract CBD at a lower cost. The Company has signed an initial extraction contract in Europe to be the exclusive extractor for Dragonfly Biosciences LLC, a United Kingdom-based supplier of CBD. The Company also recently completed the acquisition of Olimax NT SP. Z .O.O, a multi-generational hemp agricultural firm that is expected to increase the Company's market share in the European CBD industry.

On Behalf of the Board
Jason Dussault, CEO

CONTACT:

Mauricio Inzunza
Mauricio@stillcanna.com
1(844)-442-STILL (7845)

Cautionary Note Regarding Forward Looking Statements: This release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws, including that the Company anticipates adding additional certificates to the B2B web portal, the Company anticipates ongoing monthly shipments of CBD Isolate to Biosciences offices globally, the Company anticipates fulfilling its HempLabs order by the end of December, the Company anticipates shipping hemp to Sequoya on an ongoing monthly basis,, the Company anticipates sending additional product samples to various potential customers within the next 10 days, the Company plans to operate the Nexus facility 24 hours a day for 7 days a week and the Company anticipates monetizing the sale of the hemp components that are not utilized during the CBD Isolate distilling process. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should" or "would" occur. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the Company will add additional certificates to the B2B web portal, the Company will make ongoing monthly shipments of CBD Isolate to Biosciences offices globally, the Company will fulfill its HempLabs order by the end of December, the Company will ship hemp to Sequoya on an ongoing monthly basis,, the Company will send additional product samples to various potential customers within the next 10 days, the Company will successfully operate the Nexus facility 24 hours a day for 7 days a week and the Company will successfully monetize the sale of the hemp components that are not utilized during the CBD Isolate distilling process. Although the Company considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect, and the forward-looking statements in this release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking statements. Such risk factors may include, among others, that the Company will not add additional certificates to the B2B web portal, the Company will not make ongoing monthly shipments of CBD Isolate to Biosciences offices globally due to lack of demand or unanticipated supply line or production problems, the Company will not fulfill its HempLabs order by the end of December due to unanticipated supply line or production problems, the Company will not ship hemp to Sequoya on an ongoing monthly basis,, the Company will not send additional product samples to various potential customers within the next 10 days, the Company will not successfully operate the Nexus facility 24 hours a day for 7 days a week and the Company will not successfully monetize the sale of the hemp components that are not utilized during the CBD Isolate distilling process. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not intend, and expressly disclaims any intention or obligation to, update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law.

The CSE has not in any way passed upon the merits of and has neither approved nor disapproved the contents of this news release.

SOURCE: Stillcanna Inc.

ReleaseID: 569976

Oncolytics Biotech(R) Announces Abstract Outlining Potential New Biomarker to be Presented at the 2020 Gastrointestinal Cancers Symposium

SAN DIEGO, CA and CALGARY, AB / ACCESSWIRE /  December 12, 2019 / Oncolytics Biotech® Inc. (NASDAQ:ONCY)(TSX:ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced the acceptance of an abstract highlighting new biomarker data from the randomized study NCI 8601: Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer. The data will be part of a poster presentation at the 2020 Gastrointestinal Cancers Symposium sponsored by ASCO, January 23 – 25, 2019, in San Francisco.

The abstract, CEACAM6 is a candidate biomarker for Reolysin® (pelareorep) sensitivity in pancreatic adenocarcinoma (PDAC), was co-authored by Dr. Anne Noonan, Department of Medical Oncology, Ohio State University Wexner Medical Center, Richard Solove Research Institute and James Cancer Hospital, and Dr. Tanios Bekaii-Saab Senior Associate Consultant, Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Phoenix, Arizona.

Abstracts will be published at 5:00 pm ET on Tuesday, January 21, 2020 on the ASCO meeting library website at https://meetinglibrary.asco.org/.

Abstract ID: 285103
Abstract Number: 746
Poster Board: M13
Abstract Title: CEACAM6 as a candidate biomarker for pelareorep sensitivity in pancreatic adenocarcinoma (PDAC)
Session Information: Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Session Date & Time: January 24, 2020 from 12:00 PM-1:30 PM & 4:30 PM-5:30 PM

About Pelareorep

Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus: a first-in-class intravenously delivered immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. The compound induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses to treat a variety of cancers and has been demonstrated to be able to escape neutralizing antibodies found in patients.

About Oncolytics Biotech Inc.

Oncolytics is a biotechnology company developing pelareorep, an intravenously delivered immuno-oncolytic virus. The compound induces selective tumor lysis and promotes an inflamed tumor phenotype – turning "cold" tumors "hot" – through innate and adaptive immune responses to treat a variety of cancers. Pelareorep has demonstrated synergies with immune checkpoint inhibitors and may also be synergistic with other approved immuno-oncology agents. Oncolytics is currently conducting and planning additional studies in combination with checkpoint inhibitors and targeted therapies in solid and hematological malignancies, as it prepares for a phase 3 registration study in metastatic breast cancer. For further information, please visit: www.oncolyticsbiotech.com.

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended and forward-looking information under applicable Canadian securities laws (such forward-looking statements and forward-looking information are collectively referred to herein as "forward-looking statements"). Forward-looking statements, including the Company's belief as to the potential and mode of action of REOLYSIN, also known as pelareorep, as a cancer therapeutic; and other statements related to anticipated developments in the Company's business and technologies involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of pelareorep as a cancer treatment, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize pelareorep, uncertainties related to the research and development of pharmaceuticals, uncertainties related to the regulatory process and general changes to the economic environment. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements, except as required by applicable laws.

Oncolytics Contact

Michael Moore
Vice President, Investor Relations & Corporate Communications
858-886-7813
mmoore@oncolytics.ca
 

Investor Relations for Oncolytics

Timothy McCarthy
LifeSci Advisors
212.915.2564
tim@lifesciadvisors.com
 

Media Contact for Oncolytics

Jason Spark
Canale Communications
619-849-6005
jason@canalecomm.com

SOURCE: Oncolytics Biotech

ReleaseID: 569968

Dimension Five Technologies Inc. Enters into a Share Exchange Agreement with Digital Cavalier Technology Services Inc.

Not for Dissemination in the United States of America

VANCOUVER, BC / ACCESSWIRE / December 12, 2019 / Dimension Five Technologies Inc. (CSE:DFT) (the "Company"), is pleased to announce that it has entered into a share exchange agreement dated December 11, 2019 (the "SEA") with Digital Cavalier Technology Services Inc. doing business as Youneeq ("Youneeq") to acquire all of the issued and outstanding securities of Youneeq (the "Transaction"). The Company and Youneeq have signed the SEA and signatures are being gathered from Youneeq shareholders in order to obtain a fully executed version. The proposed transaction is dependent on all Youneeq shareholders signing the SEA.

ABOUT YOUNEEQ (Digital Cavalier Technology Services Inc.)

Youneeq is an award-winning personalization and recommendation engine powered by artificial intelligence (AI). The company is poised to become a leading multi-channel AI personalization engine focused on the anonymous audience, the single biggest segment for marketers.

Recently L'Oréal Canada selected Youneeq, from over 150 companies evaluated for their Open Innovation Challenge, to deliver a paid proof of concept for website personalization on one of their key ecommerce websites. During the proof of concept Youneeq went head-to-head against an industry leader and its AI personalization solution. Youneeq came out ahead in almost every category and key performance indicator measured: more engagement with product recommendations, higher conversions on calls to action, and increased revenue. Youneeq's technology is validated, and market-ready, with a $20 billion current global market potential.

EXPERIENCED AND HIGH-PROFILE TEAM

Youneeq is led by Murray Galbraith, who has over 30 years of experience in leading transformative tech companies and the Founder of Youneeq from inception; Stefan Eyram, Chief Revenue Officer (head of sales and marketing), who has led Canadian sales for ExactTarget (prior to acquisition by Salesforce.com), Sailthru (acquired by CM Group) and Dynamic Yield (acquired in 2019 by McDonald's for US$300M); and CTO, Mike Lally, who has assisted some of the worlds largest brands like IBM and EDS in technology development, and whose background is in big data and data modelling.

PROBLEM & OPPORTUNITY

Today digital marketers spend the overwhelming bulk of their budgets on branding and acquiring website visitors; and most of their time and resources are spent on converting and retaining known visitors and customers. In fact, it is estimated companies spend only 1-2% as much on converting the anonymous audience as they do to acquire them. However, according to Adobe 98% of these website visitors are anonymous (not known) and over 50% of them leave a website without doing anything. This "Anonymous Gap" is a big problem and a big opportunity!

The world's leading research and advisory company, Gartner, says customer experience is the new battlefield for companies. According to Bain, 80% of companies believe they deliver "super experiences" however, only 8% of their customers agree. Executives and companies have woken up, with over 90% believing there is value in personalized marketing, with companies of all sizes now flocking to AI-powered personalization because they are afraid they may lose their customers due to the shift in customer expectations.

This is underscored by Amazon, who takes in approximately 50% of all US ecommerce revenues. They have already proven the value of personalization and recommendations by driving 30% of their sales this way. Youneeq in an advantageous position to be the leader in solving the under-served anonymous gap problem for companies and begin to get significant market share out of this fast-growing $20 million market.

PRODUCT & SOLUTION: YOUNEEQ AI

Youneeq AI addresses the "anonymous gap" by using proven artificial intelligence and machine learning to automatically match the right content to the right person at the right time. The technology captures and analyzes website visitor behavior as well as website content and how visitors engage with it. Content can include products, articles, videos, calls to action, offers, instructions, ratings & reviews, and much more. Using proven predictive models and real-time decision services Youneeq AI selects the right content to engage and convert each visitor; whether it's their first time on a site and they are anonymous, if they are a returning visitor (either anonymous or known), or if they are already known and identified (an email subscriber, past customer or similar).

Youneeq has the significant advantage of being an early mover in the market after starting 4 years ago. It has worked on hundreds of content and ecommerce websites to develop and train sophisticated algorithms. This need for both time and mass amounts of data is a barrier to entry for many companies.

POTENTIAL RETURN/REVENUE MODEL

Youneeq is built on a Software-as-a-Service (SaaS) model based on annual subscription licenses generating monthly recurring revenues (MRR). By nature the SaaS model allows for quick and massive scaling while allowing for high profit margins and generating significant recurring revenues.

COMPETITION AND ACQUISITIONS

Companies providing solutions in the personalization and recommendation space generally fall into one of two categories: 1) independent or 3rd-party solutions that integrate with existing websites and content management platforms, or 2) content management and ecommerce platforms with native or built-in functionality.

Driven by strong demand in AI personalization, the personalization industry has seen many recent acquisitions. In 2019 alone 3rd-party solution Dynamic Yield was acquired by McDonald's Restaurants for USD$300M while Sailthru, Monetate, Certona and Rich Relevance were all acquired for significant sums.

Competitors with native personalization functionality integrated within their content management and ecommerce platforms include enterprise solutions such as Salesforce.com (Commerce Cloud), Adobe (Experience Manager and Magento), SAP (Hybris), Sitecore and others.

While some competitive solutions do not use AI for personalization, the trend is to go this route. However, none of the available solutions focus on the anonymous audience, and solving the anonymous gap, preferring to work mainly with known or identified users typically saved in Customer Relationship Management (CRM) databases. The big issue associated with known visitors is that they typically represent only 2-10% of a company's total website audience.

Furthermore, over 75% of global websites do not leverage any sort of dynamic content personalization.

THE YOUNEEQ ADVANTAGE

The Youneeq advantage can be summed up in 5 key points:

Deliver increased engagement, conversion and revenue across all website visitors, especially the under-served anonymous audience.
Proven solution validated by a major global corporation in head-to-head tests against an industry-leading solution with AI.
Fast-growing $20 billion potential market.
Proven team of industry experts with previous experience helping scale multiple companies that made significant exits.
Product is developed, validated, and ready to scale right now.

THE TRANSACTION

Pursuant to the SEA, the Company proposes to acquire all of the issued and outstanding common shares of Youneeq in exchange for a total of 75,000,000 common shares of the Company (the "Payment Shares"). The Payment Shares will be issued to the shareholders of Youneeq on a pro-rata basis, including existing shareholders of Youneeq and Youneeq shareholders to be added under a financing Youneeq is undertaking prior to closing.

On or before the closing of the Transaction, it is proposed that the Company will complete an equity financing of units comprising common shares and common share purchase warrants (the "Concurrent Financing") by way of a non-brokered private placement to raise gross proceeds of up to CAD$1,000,000 at a price of $0.05 per unit. Youneeq will also raise up to $250,000 in a private placement of its shares (the "Youneeq Financing"), and if it raises less than $250,000, the number of Payment Shares will be reduced by 20 Payment Shares for every $1 less than $250,000 that Youneeq raises.

The Transaction is conditional upon, among other things:

i. the parties receiving all necessary regulatory and third-party consents, approvals and authorizations as may be required in respect of the Transaction, including, but without limitation, acceptance of the CSE;

ii. completion of due diligence to the satisfaction of the parties;

iii. the signing of the SEA by all Youneeq shareholders and private placement investors;

v. completion of all matters, and the satisfaction of all conditions (unless waived in writing), under the SEA required to be completed or satisfied on or before closing of the Transaction including but not limited to: receipt by Youneeq of a loan of $25,000 from the Company on full execution of the SEA; completion of the Concurrent Financing and the Youneeq Financing; and

vi. the shareholders of the Company (including if required by a majority of the minority shareholders) will have approved the Transaction and any and all matters in connection therewith pursuant to applicable laws and the rules and policies of the CSE.

In connection with the Transaction, it is intended that the Company will be re-named as Youneeq AI Technologies Inc. or other name as the parties may reasonably agree upon and as is acceptable to the CSE (the "Resulting Entity"). Upon completion of the Transaction the Resulting Entity will carry on the business currently conducted by Youneeq and will cease to carry on the business currently being conducted by the Company. It is also intended that concurrent with the closing of the Transaction, the board of directors and officers of the Resulting Entity will be reconstituted.

PROPOSED MANAGEMENT TEAM

The following persons are proposed to become directors and officers of the Resulting Entity:

Murray Galbraith: Director and CEO
James D. Romano: Director
Russ Lazaruk: Director
Stefan Eyram: Chief Revenue Officer
Mike Lally: Chief Technology Officer
Craig Murata: CFO
2 Additional directors to be named by the Company.

ADDITIONAL INFORMATION

The SEA regarding the proposed Transaction and the Resulting Entity will be filed on SEDAR and will be available for viewing by all shareholders. If completed, the Transaction will constitute a "Fundamental Change" pursuant to CSE policies. The SEA incorporates the principal terms of the Transaction described herein, and in addition, such other terms and provisions of a more detailed structure and nature as the parties have agreed.

However, there is no guarantee that the Transaction will close. And if it does close, the Resulting Entity will have to qualify to list its shares for trading on the CSE under a Listing Application or similar disclosure document.

TRADING HALT

Under CSE rules, trading in the Company's shares will remain halted until the Company either closes the Transaction or terminates the SEA.

ABOUT US (Dimension Five Technologies Inc.)

Dimension Five Technologies Inc., based in Vancouver, British Columbia, Canada, has been developing a new investing platform that helps connect early stage companies with investors. The Company is looking to change its main business activities as set out in this press release. Additional information on Dimension Five is available on the company's website at http://www.dimensionfive.ca.

For further information, please contact:

Chris Parr, CEO

Chris@dimensionfive.ca

The Canadian Securities Exchange has not reviewed, nor approved the contents of this news release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or sold in the "United States", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

Forward-Looking Statements

Completion of the Transaction is subject to a number of conditions, including but not limited to, execution of the SEA by Youneeq shareholders, financings by both Youneeq and the Company, CSE acceptance and, pursuant to the requirements of the CSE, shareholder approval by a majority of the minority of shareholders. There can be no assurance that the Transaction will be completed as proposed or at all.

Trading in the securities of the Company should be considered highly speculative.

All information in this news release concerning Youneeq has been provided for inclusion herein by Youneeq. Although the Company has no knowledge that would indicate that any information contained herein concerning Youneeq is untrue or incomplete, the Company assumes no responsibility for the accuracy or completeness of any such information as the Company has not completed due diligence on Youneeq.

Investors are cautioned that, except as disclosed in the listing statement or information circular to be prepared in connection with the Transaction, any information released or received with respect to the Transaction may not be accurate or complete and should not be relied upon.

Statements about the execution of the SEA, closing of the Transaction, expected terms of the Transaction, the number of securities of the Company that may be issued in connection with the Transaction, the ownership of the Company, the requirement to obtain shareholder approval, the terms of and the completion of the Concurrent Financing and Youneeq Financing, the Payment Shares and the parties' ability to satisfy any and all other closing conditions, and receive necessary regulatory and CSE approvals in connection therewith and anticipate costs and the ability to achieve goals are all forward-looking information. Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Factors that could cause the actual results to differ materially from those in forward-looking statements include, failure to negotiate the substantive business terms, items of due diligence presenting challenges to closing that cannot be overcome, failure to get financing as required, failure to get required shareholder approval, failure to get a majority of the minority shareholder approval, failure to obtain regulatory approval, the continued availability of capital and financing, and general economic, market or business conditions, changes in legislation and regulations, failure of counterparties to perform their contractual obligations, litigation, the loss of key directors, employees, advisors or consultants and fees charged by service providers. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Readers should not place undue reliance on the Company's forward-looking statements.

SOURCE: Dimension Five Technologies Inc.

ReleaseID: 569965

Global Silicon-Based Synthetic Reagents 2019 Industry Trends, Sales, Supply, Demand, Analysis & Forecast to 2024

A New Market Study, titled “Silicon-Based Synthetic Reagents Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.

Pune, India – December 12, 2019 /MarketersMedia/

Summary

A New Market Study, titled “Silicon-Based Synthetic Reagents Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.

This report provides in depth study of “Silicon-Based Synthetic Reagents Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Silicon-Based Synthetic Reagents Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This market report offers a comprehensive analysis of the global Silicon-Based Synthetic Reagents market. This report focused on Silicon-Based Synthetic Reagents market past and present growth globally. Global research on Global Silicon-Based Synthetic Reagents Industry presents a market overview, product details, classification, market concentration, and maturity study. The market value and growth rate from 2019-2025 along with industry size estimates are explained.

The latest advancements in Silicon-Based Synthetic Reagents industry and changing market dynamics are key driving factors to depict tremendous growth. Also, the risk factors which will have a significant impact on the Global Silicon-Based Synthetic Reagents industry in the coming years are listed in this report. The revenue-generating Silicon-Based Synthetic Reagents types, applications, and key regions are evaluated. Top growing regions and Silicon-Based Synthetic Reagents industry presence cover Asia-Pacific, North America, Europe, Middle East, African countries and South America. This Silicon-Based Synthetic Reagents business study also analyzes the top countries in these regions with their market potential.

Request a Free Sample Report @ https://www.wiseguyreports.com/sample-request/3940540-global-silicon-based-synthetic-reagents-market-data-survey-report-2013-2025

Key manufacturers are included based on company profile, sales data and product specifications etc.:
Gelest, Inc
TCI Chemicals
ANGUS
Sigma-Aldrich
Santa Cruz Biotechnology

The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type

Major applications as follows:
Plastic
Rubber
Adhesive
Coating

Major Type as follows:
Peterson Olefinations
Cyanosilylations
Cross-coupling Reactions

Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa

At Any Query @ https://www.wiseguyreports.com/enquiry/3940540-global-silicon-based-synthetic-reagents-market-data-survey-report-2013-2025

Major Key Points in Table of Content

1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Type
1.1.5 Scope of Regions/Countries
1.2 Global Market Size

2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 Key Manufacturers
3.1 Gelest, Inc
3.1.1 Company Information
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.1.4 Recent Development
3.2 TCI Chemicals
3.2.1 Company Information
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2.4 Recent Development
3.3 ANGUS
3.3.1 Company Information
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3.4 Recent Development
3.4 Sigma-Aldrich
3.4.1 Company Information
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Santa Cruz Biotechnology
3.5.1 Company Information
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers, , Pune – 411028, , Maharashtra, India
Phone: 6282580070
Website: https://www.wiseguyreports.com/sample-request/3940540-global-silicon-based-synthetic-reagents-market-data-survey-report-2013-2025

Source URL: https://marketersmedia.com/global-silicon-based-synthetic-reagents-2019-industry-trends-sales-supply-demand-analysis-forecast-to-2024/88939025

Source: MarketersMedia

Release ID: 88939025

Cancer Immunotherapy Market to Register Double-digit Growth in 2020, as Conventional Therapies Lose Sheen, Finds Fact.MR

The study indicates that the players in the cancer immunotherapy market space can expect a marginal rise in the demand for cancer immunotherapy, with an estimated CAGR of 15% during the forecast period (2020-2025).

Rockville, United States – December 12, 2019 /MarketersMedia/

A recent report published by Fact.MR points towards disequilibrium in the distribution of cancer immunotherapy in developing and developed regions. In the U.S., high frequency of knowledge-based awareness campaigns encourages individuals to undergo cancer diagnostics, and government-led insurance plans cover high treatment spending.

In stark contrast, developing countries such as Brazil and Argentina lack primary cancer treatment tools. A similar scenario is witnessed in South Africa, where the mortality rate is high, owing to the late diagnosis of cancer. Developing countries of Asia Pacific with high population density and average penetration of quality treatment are serving as high potential cancer immunotherapy markets.

Analysing a number of dynamics, the Fact.MR study foresees high opportunities in developing regions such as Latin America, the Middle East & Africa, and Asia Pacific, and projects nearly 1.7X growth of the cancer immunotherapy market during the forecast period (2020-2025).

Request Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=4367

Key Highlights of Cancer Immunotherapy Market Study

– Qualitative approach of therapeutic development turns highly cost-intensive for players in the cancer immunotherapy market. Additionally, high product rejection in trial phases leads to huge losses, which discourages manufacturers towards the development of new therapeutics.

– Progressive rise in the popularity of generic drugs, on account of the affordability factor, is diverting the patient base from spending on branded drugs, thereby weakening the sales prospects of manufacturers.

– Incentives offered by central healthcare authorities on development of ‘orphan drugs’ are encouraging established manufacturers to venture into this space.

– Though hospitals are holding a dominant position as end users in the cancer immunotherapy market, a shift of patients towards clinics will remain noteworthy for market players, on account of shorter wait windows and improvements in healthcare services offered by these institutions.

A healthcare industry expert at Fact.MR infers, “Manufacturers can increase focus towards the development of anticancer drugs, particularly for lung cancer, given the influence of the multitude of drivers adversely impacting the health of lungs. By 2025, the adoption of immunotherapies to treat lung cancer would be valued at US$ 38 Bn.”

Request Research Methodology- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4367

Threat from Conventional Therapies to Remain Growth Barrier for Manufacturers

Lack of proper awareness regarding advanced cancer treatment implies that, conventional therapies such as radiography and chemotherapy will not go obsolete, at least in the near future. Manufacturers are intensifying efforts towards product innovation to achieve orphan drug status and ensure high marketability.

Pfizer, Inc. best illustrates this strategy. The company has taken multiple initiatives such as collaborations, alliances, mergers, and licensing agreements to launch biologics and receive orphan status for its products. Monetary support from governments to manufacturers, with an intent to develop a promising pipeline of cancer therapeutics, is attracting a large number of new entrants, especially in North America. However, leading players would encounter a low threat of new entrants, on account of their high developmental knowhow and strong distribution networks.

Find More Valuable Insights on Cancer Immunotherapy Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global cancer immunotherapy market, presenting historical demand data (2016-2019), and forecast statistics for the period of 2020-2025. The study divulges compelling insights on the cancer immunotherapy market on the basis of therapy (monoclonal antibodies, immune checkpoint inhibitors, immune system modulators, cancer vaccines, and others), cancer type (lung cancer, colorectal cancer, breast cancer, prostate cancer, melanoma, blood cancer, and others), and end user (hospitals, ambulatory surgical centres, cancer research centres, and clinics), across five major regions.

To get more insights on cancer immunotherapy market, visit- https://www.factmr.com/report/4367/cancer-immunotherapy-market

About the Healthcare Division at Fact.MR

The healthcare team at Fact.MR assists clients with unique business intelligence needs on a global level. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analysed the healthcare industry to a micro-level across 50+ countries for over a decade. The team provides end-to-end research and consulting services to help keep clients at the top of the game. Reach out to us to know how we can help.

Contact Info:
Name: James Hilton
Email: Send Email
Organization: Fact.MR
Website: https://www.factmr.com/

Source URL: https://marketersmedia.com/cancer-immunotherapy-market-to-register-double-digit-growth-in-2020-as-conventional-therapies-lose-sheen-finds-factmr/88939026

Source: MarketersMedia

Release ID: 88939026

Beautologie Cosmetic Surgery and Medical Aesthetics Specializes in Injectable Treatments and Fillers

BAKERSFIELD, CA / ACCESSWIRE / December 12, 2019 / Medical and technological advances in combination with a growing focus on quality of life have been driving the aesthetic procedures market, further supported by the increasing affordability of the most common beauty treatments and the improving effectiveness of the products. Among the most popular procedures are those involving injectables and dermal fillers as they deliver quick results and long-lasting effects. Global Market Insights estimates that dermal filler sales will surpass $8.5 billion by 2024, while Grand View Research projects that hyaluronic acid dermal fillers – the most popular solutions in the wrinkle removal category – will be a market worth $6.04 billion by 2025, expanding at a compound annual rate of 8.3%. California-based cosmetic surgery and medical aesthetics specialist Beautologie says there has been a surge in the number of people seeking to improve their appearance via non-invasive beautification procedures, and the company has earned an enviable reputation for delivering excellent results for patients who opt to undergo aesthetic treatments with injectables and dermal fillers.

There is an impressive choice of products that can rejuvenate the face, including popular injectable wrinkle relaxers Botox Cosmetic, Xeomin, Dysport, and Jeuveau and dermal fillers such as Restylane, Perlane/Restylane Lyft, and Juvederm. The latter group can be used in cases when patients require lip enhancement, deep creases smoothing, smoker lines diminishment, or cheekbones restoration. Aside from being highly effective, these products have long-lasting results, typically between six and 12 months. Dr. Darshan Shah, one of Beautologie's experts, notes, "The greatest thing about injectable procedures is that they can be done in the office and usually take about 20 to 30 minutes. The recovery time is generally very short – there might be a little bit of swelling, some redness, and an occasional bruise, but most of these things go away within a day or two."

Proven expertise in product application and thorough knowledge of the facial anatomy are crucial factors for achieving the desired results, Dr. Darshan Shah points out. "It is essential to seek out someone who knows what products and in what amounts to use to get not just a good but also a very nice natural result. I think it's important to look for a professional who has years of experience with these injectable treatments." Patients truly appreciate the personal touch and the effort Beautologie's specialists put into the whole process, investing sufficient time to get to know each client and suggesting the procedures and products that would work best in an individual case. Everything at the clinic is doctor-supervised or doctor-administered, in sharp contrast to the typical practices at medical spas or neighborhood salons, and patients greatly value this professional dedication, according to Dr. Shah.

Beautologie has become the destination of choice for Californians wishing to improve their physical appearance through cosmetic surgery or medical aesthetics procedures. Unrelentingly focused on patient comfort, quality work, and safety, the company has won multiple awards, among them the title of Best Bakersfield Plastic Surgeon (Dr. Darshan Shah) for 15 consecutive years. In addition to its team of highly trained doctors, Beautologie boasts fully AAAHC-accredited facilities and an unrivaled 100% safety record. Utilizing a collaborative approach, the company's specialists deliver the best possible care while ensuring that patients receive exemplary personalized treatment and experience the utmost satisfaction with the results.

Beautologie – Cosmetic Surgery and Medical Aesthetics in California: http://beautologienews.com
Beautologie (@beautologie) – Twitter: https://twitter.com/beautologie
Bakersfield Beautologie Has Been Voted Best 13 Years in a Row: https://www.drshah.com/bakersfield.html

Contact Information:
Beautologie
Michael Wittaker
mwhittaker@beautologie.com
https://www.beautologie.com
1-844-232-8865

SOURCE: Beautologie

ReleaseID: 570015

Consumer Attraction for Portable Solar Chargers Intensifies as Innovations Abound, Finds Fact.MR

New study projects that the global portable solar charger market growth at 7.5%, between 2019 and 2029.

Rockville, United States – December 12, 2019 /MarketersMedia/

The recent past has witnessed a significant surge in the adoption of sustainable technology. Consumer preference for for long term durability and usage of on-the-go technologies has fueled adoption of portable solar chargers. North America continues to lead in the demand for portable solar chargers, accounting for more than 30% of the market share. The trade war between United States and China has gnawed into profits of domestic as well as foreign portable solar charger manufacturers. However, market is expected to show a northward trend, due to substantial increase in demand from adventure seeking millennials and Generation Z. While Europe and North America can be construed as established markets for portable solar chargers, significant is expected in later half of forecast period.

Key Takeaways from the Portable Solar Charger Market

– North America accounts for 1/3rd stake in portable solar chargers market, and is expected to present a gradual growth trend. The trade war with China has affected raw material inflow like solar panels for portable solar chargers for United States based manufacturers.

– Asia Pacific region is expected to present nearly 2X growth over value in 2019. Growth trend in East Asia is expected to be higher than in South Asia.

– European Union still remains at the forefront for solar power adoption and is expected to show substantial growth in demand for portable solar chargers.

Request Report Sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=4368

– Monocrystalline solar panels are expected to govern portable solar chargers for regions in growth stage like North America and Europe. In global portable solar chargers market, share lost by polycrystalline solar panels is captured by monocrystalline solar panels.

– Polycrystalline panels in portable solar chargers are projected to portray a bearish trend, similar to its erstwhile historical decline.

– Foldable segment of portable solar chargers is a leading segment in terms of value. However, small portable solar chargers lead the market in terms of volume.

“Customers of portable solar chargers are highly price sensitive, which is also reflected in terms of the fragmented structure of the market. Mid-to-small sized companies offering low-priced portable solar chargers account for a significant share, however, a transformation in the market structure is expected in the coming decade. An anticipated consumers’ shift towards established brands with a higher price tag is expected to witness a spurt in demand. ”, says the Fact.MR analyst.

Request Research Methodology- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4368

Portable Solar Charger Manufacturers banking on Untapped Markets for Profitability

Currently portable solar chargers market is highly fragmented, with tier 1 players accounting for only one fifth of total market share. Key competitors in the market have focused on increasing their product portfolio and domestic market presence. Majority of top players in portable solar chargers market are based in United States, but expansion in other regions is being observed. Jackery Inc. one of the major companies in portable solar charger market, has entered Japan. Expansion in Japan is with establishment of manufacturing facilities and partnership with JVCKENWOOD Corporation. Even though companies have focused on establishing a foothold in domestic markets, the trend of regional expansion is expected to be carried out by other portable solar charger manufacturers as well.

Find More Valuable Insights on Portable Solar Chargers Market

Fact.MR, in its new offering, brings to fore an unbiased analysis of the global portable solar chargers market, presenting historical demand data (2014-2018) and forecast statistics for the period, 2019-2029. The study divulges compelling insights on the portable solar chargers market on the basis of product type (small portable, foldable and semi portable), panel type (monocrystalline, polycrystalline and others) and panel size in terms of wattage (less than 10W, 10W to 50W and more than 50W) across seven major regions.

To get more information on portable solar chargers market, visit- https://www.factmr.com/report/4368/portable-solar-chargers-market

About the Retail and Consumer Goods Division at Fact.MR

Being a consortium of large number of sub-industries, not many market research companies are being able to fulfil the requirements of consumer product clients. Though, Fact.MR retail and consumer goods analysts at Fact.MR have been categorically tracking the broader sub-industries to keep themselves abreast of the recent happenings in the market. Our practical approach to product design and pricing strategy contributes to the growth of businesses that are struggling to hit the ‘move-the-needle’ bottom line. With unmatched analytical diligence, the team at Fact.MR helps organizations design product differentiation strategies and introduce exclusive product(s) to their existing portfolio. For more information on our deep domain expertise, click here.

Contact Info:
Name: James Hilton
Email: Send Email
Organization: Fact.MR
Website: https://www.factmr.com/

Source URL: https://marketersmedia.com/consumer-attraction-for-portable-solar-chargers-intensifies-as-innovations-abound-finds-factmr/88939032

Source: MarketersMedia

Release ID: 88939032

Thu Mua Phe Lieu Thinh Phat Named Biggest Scrap Dealer in Vietnam

Thu Mua Phe Lieu Thinh Phat becomes the biggest scrap dealing organization in Vietnam with increasing clientele.

Hochiminh, Vietnam – December 12, 2019 / /

Thu Mua Phe Lieu Thinh Phat has been named as the biggest scrap dealer in Vietnam in recent times. This organization deals with all kinds of scrap metal, which include aluminum, iron and copper scraps, etc. One of the reasons as to why they named best in the business is due to their massively satisfied clientele. With the best offers given to customers, people try to sell their scraps to this firm instead of anywhere else.

The company wanted to be at the top of this industry and started small, but within just a few years, it developed and is currently the best company in this business sector. However, with the recent developments and accolades received, they aim at becoming a popular name globally, but that’s a far-sighted option.

The CEO of this organization mentioned, “We knew that numerous people were trying to get rid of scraps like metal containers, mechanical equipment, old machinery and more but weren’t able to sell at a good price. So, we started buying scraps at the best market price and secured our clientele. Most of our clients are repeat sellers due to their nature of the business, which helped us become the best in the scrap dealing industry.”

Also, the company’s success largely depends on the price quotation it offers to all its clients. It helps them to understand an approximate amount one would receive from selling scrap to this firm and act accordingly. Now the company is planning to expand its operations to every corner of this nation and later do business on a global scale. However, it will take a few years to execute this plan of theirs.

The company is expecting to receive a few more awards before the financial year ending. They believe that their success is just starting to soar and is expected to reach great heights soon enough. Also, their profit has been more than the last few years’ gains and that too with the last quarter still left. How much success this company will get more, it’s just a matter of time for people to know.

According to the VP of this scrap dealing firm, “We want the best for our customers, which is why we provide the best services and market price for every deal we make. Such remarkable service and customer satisfaction are what led our company to the highest level of success it is enjoying right now.”

Though this company has colossal plans for the future, for now, they are just enjoying their success with their staff and clients. However, it seems more success is definitely on their way.

About the company:
Thu Mua Phe Lieu Thinh Phat is a scrap dealing business. They are known for buying iron, aluminum, and copper scraps at large quantities from their clients regularly. Their team of professional scraps dealers and customer service consultants offer services that made them become the best company in this industry.

Contact Details:
Pinterest: https://www.pinterest.com/vutienhung1/
Reddit: https://www.reddit.com/user/vutienhung
Tumblr: https://www.tumblr.com/blog/vu-tien-hung
Linkedin: https://www.linkedin.com/in/vutienhung/
Instapaper: https://www.instapaper.com/p/vutienhung

Contact Info:
Name: John
Email: Send Email
Organization: Thu Mua Phe Lieu Thinh Phat
Address: 653 To Ngoc Van, Thu Duc District, HCMC
Phone: +84 983.153.979
Website: https://thumuaphelieuthinhphat.com/

Source:

Release ID: 88938947